DongKoo Bio & Pharma Co., Ltd.
http://www.dongkoo.com/eng
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From DongKoo Bio & Pharma Co., Ltd.
Korean Biopharma Financings Remain In Doldrums But Recovery In Sight?
As investor sentiment around Korean biopharma IPOs and financings remained tepid in the second quarter, companies turned to other ways of raising money, including rights offerings. But there are signs of recovery and upcoming catalysts, while on the M&A front Boryung divested a vaccine subsidiary to a private equity consortium.
Company Information
- Industry
- Distributors
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice